Insurers often take one to two weeks to evaluate the paperwork, check eligibility, and make a decision
It is necessary for the metabolism of carbohydrates, amino acids, and fats
It is marketed as Mounjaro for type 2 diabetes (approved by the FDA in 2022) and as Zepbound for chronic weight management (approved in 2023), with corresponding approvals in other jurisdictions
Importantly, this effect often attenuates over time with long-acting agents (tachyphylaxis), though the weight loss and glycemic benefits typically persist
It is important not to significantly restrict fluid or food intake beyond what the medication naturally induces, as this can lead to nutritional deficiencies or dehydration
Over-the-counter (OTC) Topicals